121 related articles for article (PubMed ID: 38388357)
1. Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
Huang X; Chen X; Wan G; Yang D; Zhu D; Jia L; Zheng J
BMC Cancer; 2024 Feb; 24(1):245. PubMed ID: 38388357
[TBL] [Abstract][Full Text] [Related]
2. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
[TBL] [Abstract][Full Text] [Related]
3. Alterations in gut microbiota of esophageal squamous cell carcinoma patients.
Cheung MK; Yue GGL; Lauw S; Li CSY; Yung MY; Ng SC; Yip HC; Kwan HS; Chiu PWY; Lau CBS
J Gastroenterol Hepatol; 2022 Oct; 37(10):1919-1927. PubMed ID: 35816164
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome can predict chemoradiotherapy efficacy in patients with esophageal squamous cell carcinoma.
Sasaki T; Matsumoto Y; Murakami K; Endo S; Toyozumi T; Otsuka R; Kinoshita K; Hu J; Iida S; Morishita H; Nishioka Y; Nakano A; Uesato M; Matsubara H
Esophagus; 2023 Oct; 20(4):691-703. PubMed ID: 37086309
[TBL] [Abstract][Full Text] [Related]
5. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
6. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
7. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of the presence of
Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
[TBL] [Abstract][Full Text] [Related]
9. The role of microbiota in esophageal squamous cell carcinoma: A review of the literature.
Chiang HC; Hughes M; Chang WL
Thorac Cancer; 2023 Oct; 14(28):2821-2829. PubMed ID: 37675608
[TBL] [Abstract][Full Text] [Related]
10. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Esophageal Microbiota and Prediction of the Metabolic Pathways Involved in Esophageal Cancer.
Li D; He R; Hou G; Ming W; Fan T; Chen L; Zhang L; Jiang W; Wang W; Lu Z; Feng H; Geng Q
Front Cell Infect Microbiol; 2020; 10():268. PubMed ID: 32676460
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma.
Jiang Z; Wang J; Shen Z; Zhang Z; Wang S
Front Cell Infect Microbiol; 2021; 11():774330. PubMed ID: 34858881
[TBL] [Abstract][Full Text] [Related]
14. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.
Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I
World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622
[TBL] [Abstract][Full Text] [Related]
15. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
16.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
17. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia.
Nasrollahzadeh D; Malekzadeh R; Ploner A; Shakeri R; Sotoudeh M; Fahimi S; Nasseri-Moghaddam S; Kamangar F; Abnet CC; Winckler B; Islami F; Boffetta P; Brennan P; Dawsey SM; Ye W
Sci Rep; 2015 Mar; 5():8820. PubMed ID: 25743945
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tumor-associated and nontumor-associated esophageal mucosa microbiota in patients with esophageal squamous cell carcinoma.
Zhang B; Xiao Q; Chen H; Zhou T; Yin Y
Medicine (Baltimore); 2022 Sep; 101(37):e30483. PubMed ID: 36123940
[TBL] [Abstract][Full Text] [Related]
19. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.
Lin Z; Rao W; Xiang Z; Zeng Q; Liu S; Yu K; Zhou J; Wang J; Chen W; Chen Y; Peng X; Hu Z
BMC Cancer; 2022 Jun; 22(1):696. PubMed ID: 35739509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
